Sectoral Asset Management Inc Immuno Gen, Inc. Transaction History

Sectoral Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $5.56 Million - $13.4 Million	-446,216 Reduced 96.14%	17,896 $530,000
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $389,799 - $549,703	27,665 Added 6.34%	464,112 $7.37 Million
Q2 2023 Aug 11, 2023	SELL	$3.75 - $20.05 $2.12 Million - $11.3 Million	-564,997 Reduced 56.42%	436,447 $8.24 Million
Q1 2023 May 12, 2023	BUY	$3.67 - $4.92 $724,825 - $971,700	197,500 Added 24.57%	1,001,444 $3.85 Million
Q4 2022 Feb 10, 2023	SELL	$4.55 - $6.31 $203,840 - $282,688	-44,800 Reduced 5.28%	803,944 $3.99 Million
Q3 2022 Nov 10, 2022	SELL	$4.48 - $6.47 $409,920 - $592,005	-91,500 Reduced 9.73%	848,744 $4.06 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $193,410 - $353,664	61,400 Added 6.99%	940,244 $4.23 Million
Q1 2022 May 10, 2022	BUY	$4.26 - $7.48 $3.74 Million - $6.57 Million	878,844 New	878,844 $4.18 Million
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $104,423 - $191,442	-58,013 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$2.41 - $5.91 $186,293 - $456,843	-77,300 Reduced 57.13%	58,013 $157,000
Q4 2018 Feb 12, 2019	BUY	$3.94 - $9.7 $450,342 - $1.11 Million	114,300 Added 543.95%	135,313 $650,000
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $180,711 - $236,606	21,013 New	21,013 $199,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.